Undertreatment of primary hyperparathyroidism in a privately insured US population: Decreasing utilization of parathyroidectomy despite expanding surgical guidelines-Reference-Cited by-同舟云学术

Undertreatment of primary hyperparathyroidism in a privately insured US population: Decreasing utilization of parathyroidectomy despite expanding surgical guidelines

Published:2021-01 Issue:1 Volume:169 Page:87-93
ISSN:0039-6060
Container-title:Surgery
language:en
Short-container-title:Surgery

Author:

Seib Carolyn D.^ORCID,Meng Tong,Suh Insoo^ORCID,Cisco Robin M.,Lin Dana T.,Morris Arden M.,Trickey Amber W.^ORCID,Kebebew Electron

Funder

National Institute on Aging

Publisher

Elsevier BV

Subject

Surgery

Reference24 articles.

1. The Relationship of parathyroidectomy and bisphosphonates with fracture risk in primary hyperparathyroidism: an observational study;Yeh;Ann Intern Med,2016

2. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study;Mollerup;BMJ,2002

3. End-organ effects of primary hyperparathyroidism: a population-based study;Assadipour;Surgery,2019

4. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop;Bilezikian;J Clin Endocrinol Metab,2014

5. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism;Wilhelm;JAMA Surg,2016

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parathyroidectomy and the Development of New Depression Among Adults With Primary Hyperparathyroidism;JAMA Surgery;2024-09-04

2. Opportunities to improve the diagnosis and treatment of primary hyperparathyroidism: retrospective cohort study;Gland Surgery;2024-07

3. Patient Characteristics, Management, and Outcomes in a Novel Cohort of Primary Hyperparathyroidism;Journal of the Endocrine Society;2024-05-09

4. Focus on Non-osteoporotic Post-menopausal Women with Asymptomatic Primary Hyperparathyroidism: A Monocentric Series;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-05-07

5. Chirurgische Therapie kritischer Hyperkalzämien und hyperkalzämischer Krisen;Allgemein- und Viszeralchirurgie up2date;2024-05